A detailed history of Bank Of America Corp transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,607 shares of BCLI stock, worth $2,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,607
Previous 1,492 7.71%
Holding current value
$2,281
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.22 - $0.42 $25 - $48
115 Added 7.71%
1,607 $0
Q2 2024

Aug 14, 2024

BUY
$0.34 - $0.74 $167 - $364
492 Added 49.2%
1,492 $0
Q1 2024

May 15, 2024

SELL
$0.28 - $0.66 $15 - $35
-54 Reduced 5.12%
1,000 $0
Q4 2023

Feb 14, 2024

SELL
$0.15 - $0.4 $618 - $1,650
-4,125 Reduced 79.65%
1,054 $0
Q2 2023

Aug 14, 2023

BUY
$2.0 - $3.2 $654 - $1,046
327 Added 6.74%
5,179 $10,000
Q1 2023

May 12, 2023

SELL
$1.43 - $3.3 $1,399 - $3,230
-979 Reduced 16.79%
4,852 $16,000
Q4 2022

Feb 10, 2023

BUY
$1.37 - $4.42 $584 - $1,887
427 Added 7.9%
5,831 $9,000
Q3 2022

Nov 14, 2022

SELL
$2.55 - $4.42 $5,627 - $9,754
-2,207 Reduced 29.0%
5,404 $23,000
Q2 2022

Aug 12, 2022

BUY
$2.71 - $3.6 $1,054 - $1,400
389 Added 5.39%
7,611 $21,000
Q1 2022

May 16, 2022

BUY
$2.92 - $4.19 $12,059 - $17,304
4,130 Added 133.57%
7,222 $24,000
Q4 2021

Feb 08, 2022

SELL
$2.81 - $4.23 $24,264 - $36,526
-8,635 Reduced 73.63%
3,092 $12,000
Q3 2021

Nov 15, 2021

SELL
$3.14 - $4.09 $77,209 - $100,569
-24,589 Reduced 67.71%
11,727 $38,000
Q2 2021

Sep 13, 2021

BUY
$3.01 - $4.01 $109,311 - $145,627
36,316 New
36,316 $138,000

Others Institutions Holding BCLI

About BRAINSTORM CELL THERAPEUTICS INC.


  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $51.8M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.